Significant Ownership of Otto Erik
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Otto Erik focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- Erik Otto - Individual
- Manager location
- Victoria, British Columbia, Canada
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Otto Erik with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Otto Erik
Significant Ownership of Otto Erik
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| GLTO | Chemomab Therapeutics Ltd. | American Depository Shares, each of which represent twenty ordinary shares, no par value | 6.3% | 385,000 | -77% | Otto Erik | 10 Feb 2026 |
Schedules 13D/G Reported by Otto Erik:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.